900718-02-7

Basic information

• Product Name: 2-AZEPAN-1-YL-PROPYLAMINE
• Synonyms: 2-AZEPAN-1-YL-PROPYLAMINE;2-(1-Azepanyl)-1-propanamine
• CAS NO: 900718-02-7
• Molecular Formula: C9H20N2
• Molecular Weight: 156.2685
• Mol File: 900718-02-7.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 221.6±8.0 °C(Predicted)
• Appearance: /
• Density: 0.913±0.06 g/cm3(Predicted)
• PKA: 10.23±0.10(Predicted)
• CAS DataBase Reference: 2-AZEPAN-1-YL-PROPYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AZEPAN-1-YL-PROPYLAMINE(900718-02-7)
• EPA Substance Registry System: 2-AZEPAN-1-YL-PROPYLAMINE(900718-02-7)

Safety Data

• Hazard Codes: Xi
• Statements: 36
• Safety Statements: 26
• HazardClass: IRRITANT
• Hazardous Substances Data: 900718-02-7(Hazardous Substances Data)

Usage

Also known as

N-aminoethylpiperazine

Classification

Aliphatic amine

Physical properties

Colorless to pale yellow liquid, slight amine odor, soluble in water and alcohols

Uses

Intermediate in the synthesis of pharmaceuticals and other organic compounds, production of surfactants, corrosion inhibitors, and polymers, key component in the manufacturing of various chemical products, ingredient in pesticide formulations

Industrial applications

Wide range of uses in pharmaceutical, chemical, and agricultural industries.

Upstream product

• 1622401-49-3 (S)-2-(azepan-1-yl)propanamide 
• 629-03-8 1 ,6-dibromohexane 

Relevant articles and documents

CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE AND METHODS FOR MAKING AND USING THEM

In alternative embodiments, the invention provides nucleophilic hydroxyimino- acetamido alkylamine antidotes that cross the blood-brain barrier (BBB) to catalyze the hydrolysis of organophosphate (OP)-inhibited human acetylcholinesterase (hAChE) in the central nerve system (CNS). The hydroxyimino-acetamido alkylamines of the invention are designed to fit within AChE active center gorge dimensions, bind with reasonable affinity, and react with the conjugated phosphate atom in the gorge. The hydroxyimino- acetamido alkylamines of the invention are also designed to possess ionization states that govern affinity and reactivity for the two linked hAChE re-activation steps. In alternative embodiments, the invention provides pumps, devices, subcutaneous infusion devices, continuous subcutaneous infusion devices, infusion pens, needles, reservoirs, ampoules, a vial, a syringe, a cartridge, a disposable pen or jet injector, a prefilled pen or a syringe or a cartridge, a cartridge or a disposable pen or jet injector, a two chambered or multi- chambered pump, a syringe, a cartridge or a pen or a jet injector, comprising a compound of the invention.